Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Mallinckrodt
Argus Health
Merck
McKesson
AstraZeneca

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 5,770,400

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,770,400
Title: Exogenous gene expression vector containing chick .beta.-actin gene promoter
Abstract:An expression vector for the expression of an exogenous gene in an animal cell, which contains a chick .beta.-actin gene promoter and a restriction enzyme site for incorporating an exogenous gene at the downstream of said promoter and a process for expressing an exogenous gene, which comprises incorporating said exogenous gene into the expression vector at the restriction enzyme site for incorporating the exogenous gene, introducing said vector into an animal cell and culturing the obtained transformed animal cell. The expression system of the present invention can be applied to an expression of any exogenous gene and has an extremely high expression efficiency and is applicable to a wide range of host cells, and hence can sufficiently be utilized for industrial-scale production of a useful material.
Inventor(s): Miyazaki; Junichi (Kumamoto, JP), Yamamura; Ken-ichi (Kumamoto, JP), Araki; Masatake (Kumamoto, JP), Yonemura; Hiroshi (Kumamoto, JP), Nozaki; Chikateru (Kumamoto, JP)
Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute (Kumamoto, JP)
Application Number:08/814,468
Patent Claims:see list of patent claims

Details for Patent 5,770,400

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Juridical Foundation The Chemo-Sero-Therapeutic Research Institute (Kumamoto, JP) 2008-06-24 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Juridical Foundation The Chemo-Sero-Therapeutic Research Institute (Kumamoto, JP) 2008-06-24 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Juridical Foundation The Chemo-Sero-Therapeutic Research Institute (Kumamoto, JP) 2008-06-24 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
Mallinckrodt
Deloitte
Harvard Business School
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.